Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2004 1
2010 1
2011 2
2012 2
2014 5
2015 3
2016 1
2017 3
2018 3
2019 1
2020 5
2021 2
2022 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis.
Ranallo N, Iamurri AP, Foca F, Liverani C, De Vita A, Mercatali L, Calabrese C, Spadazzi C, Fabbri C, Cavaliere D, Galassi R, Severi S, Sansovini M, Tartaglia A, Pieri F, Crudi L, Bianchini D, Barone D, Martinelli G, Frassineti GL, Ibrahim T, Calabrò L, Berardi R, Bongiovanni A. Ranallo N, et al. Among authors: barone d. Cancers (Basel). 2022 Jun 30;14(13):3231. doi: 10.3390/cancers14133231. Cancers (Basel). 2022. PMID: 35805003 Free PMC article.
Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer.
Bleve S, Cursano MC, Casadei C, Schepisi G, Menna C, Urbini M, Gianni C, De Padova S, Filograna A, Gallà V, Rosti G, Barone D, Chovanec M, Mego M, De Giorgi U. Bleve S, et al. Among authors: barone d. Front Oncol. 2022 Jun 10;12:910087. doi: 10.3389/fonc.2022.910087. eCollection 2022. Front Oncol. 2022. PMID: 35756636 Free PMC article. Review.
3-T magnetic resonance-guided high-intensity focused ultrasound (3 T-MR-HIFU) for the treatment of pain from bone metastases of solid tumors.
Bongiovanni A, Foca F, Oboldi D, Diano D, Bazzocchi A, Fabbri L, Mercatali L, Vanni S, Maltoni M, Bianchini D, Casadei C, Matteucci F, Nanni O, Rossi B, Sintuzzi E, Martoni ME, Zavoiu V, Barone D, Altini M, Ibrahim T. Bongiovanni A, et al. Among authors: barone d. Support Care Cancer. 2022 Jul;30(7):5737-5745. doi: 10.1007/s00520-022-06990-y. Epub 2022 Mar 24. Support Care Cancer. 2022. PMID: 35332373
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab.
Palleschi M, Prochowski Iamurri A, Scarpi E, Mariotti M, Maltoni R, Mannozzi F, Barone D, Paganelli G, Casi M, Giampalma E, De Giorgi U, Rocca A. Palleschi M, et al. Among authors: barone d. Sci Rep. 2022 Mar 1;12(1):3385. doi: 10.1038/s41598-022-07143-1. Sci Rep. 2022. PMID: 35233007 Free PMC article.
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients.
Conteduca V, Scarpi E, Wetterskog D, Brighi N, Ferroni F, Rossi A, Romanel A, Gurioli G, Bleve S, Gianni C, Schepisi G, Lolli C, Cortesi P, Matteucci F, Barone D, Paganelli G, Demichelis F, Beltran H, Attard G, De Giorgi U. Conteduca V, et al. Among authors: barone d. Int J Cancer. 2022 Apr 1;150(7):1166-1173. doi: 10.1002/ijc.33834. Epub 2021 Oct 13. Int J Cancer. 2022. PMID: 34605002 Free article.
Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial.
Passardi A, Rapposelli IG, Scarpi E, Neri E, Parisi E, Ghigi G, Ercolani G, Avanzolini A, Cavaliere D, Rudnas B, Valgiusti M, Barone D, Ferroni F, Frassineti GL, Romeo A. Passardi A, et al. Among authors: barone d. Ther Adv Med Oncol. 2020 Dec 8;12:1758835920977139. doi: 10.1177/1758835920977139. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33343722 Free PMC article.
38 results